Terbinafine (Lamisilr) in the treatment of onychomycosis

Journal of Dermatological Treatment

Volumn 9, Issue sup1, 1998, Pages S3-S8

  Roberts, dt ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Candidosis; Dermatophyte; Onychomycosis; Terbinafine

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; TERBINAFINE;

CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FINGER NAIL; GASTROINTESTINAL SYMPTOM; HUMAN; LIVER INJURY; ONYCHOMYCOSIS; PRIORITY JOURNAL; SKIN MANIFESTATION; TASTE DISORDER; TOE;

EID: 0031978145     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546639809160715     Document Type: Article

References (26)

1. Roberts D T. Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey. Br J Dermatol 1992; 126 (suppl 39) 23 – 7
2. Sais G, Juggla A, Peyri J. Prevalence of dermatophyte onychomycosis in Spain: a cross-sectional study. Br J Dermatol 1995; 132: 758 – 61
3. Heikkila H, Stubb S. The prevalence of onychomycosis in Finland. Br J Dermatol 1995; 133: 699 – 703
4. Summerbell R C, Kane J, Krajden S. Onychomycosis, tinea pedis and tinea manuum caused by non-dermatophyte filamentous fungi. Mycoses 1989; 32: 609 – 19
5. Zaias N, Serrano L. The successful treatment of finger Trichophyton rubrum onychomycosis with oral terbinafine. Clin Exp Dermatol 1989; 14: 120 – 3
6. Goodfield M JD. Clinical results with terbinafine in onychomycosis. J Dermatol Treat 1990; 1 (suppl 2) 55 – 7
7. Dykes P J, Thomas R, Finlay A Y. Determination of terbinafine in nail samples during systemic therapy for onychomycosis. Br J Dermatol 1990; 123: 481 – 6
8. Van der Schroeff J G, et al. A randomised treatment duration finding study of terbinafine in onychomycosis. Br J Dermatol 1992; 126 (suppl 39) 36 – 9
9. De Cuyper C. Long term evaluation of terbinafine 250mg and 500 mg daily in a 16 week oral treatment for toenail onychomycosis. Br J Dermatol 1996; 135 (suppl 1) 156 – 7
10. Jones T C. United Kingdom multicentre study. A double-blind comparison of terbinafine 250mg daily vs 125 mg daily in onychomycosis. Data on file, Sandoz Pharmaceuticals, Basel 1992
11. Atsumoto T, et al. Clinical and pharmacokinetic investigations of oral terbinafine in patients with tinea unguium. Mycoses 1995; 38: 135 – 44
12. Faergemann J, et al. Double blind, parallel group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis. J Am Acad Dermatol 1995; 32 (suppl 1) 250 – 3
13. Hofmann H, et al. Treatment of toenail onychomycosis. A randomised, double-blind study with terbinafine and griseofulvin. Arch Dermatol 1995; 131: 919 – 22
14. Haneke E, et al. Short duration treatment of fingernail dermatophytosis: a randomized, double blind study with terbinafine and griseofulvin. J Am Acad Dermatol 1995; 32: 72 – 7
15. Willemsen M, et al. Post treatment itraconazole levels in nails. New implications for treatment of onychomycosis. J Am Acad Dermatol 1992; 26: 731 – 5
16. Arenas R, Dominguez-Cherit J, Fernandez L MA. Open randomized comparison of itraconazole versus terbinafine in onychomycosis. Int J Dermatol 1995; 34: 138 – 43
17. Braütigam M, et al. Randomized double-blind comparison of terbinafine and itraconazole in the treatment of toenail tinea infection. Br Med J 1995; 311: 919 – 22
18. Br Med J 1995; 311: 1350
19. De Backer M, De Keyser P, De Vroey C, Lesaffre E. A 12 week treatment for dermatophyte toe onychomycosis: terbinafine 250mg/day vs itraconazole 200mg/day: A double blind comparative trial. Br J Dermatol 1996; 134 (suppl 46) 16 – 17
20. Tosti A, Piraccini B M, Stinchi C, Lorenzi S. Onychomycosis due to Scopulariopsis brevicaulis: clinical features and response to systemic antifungals. Br J Dermatol 1996; 135: 799 – 802
21. Havu V, et al. A study to compare the efficacy of terbinafine and fluconazole in patients with onychomycosis. Abstracts of European Academy of Dermatology and Venereology, Lisbon October, 1996
22. Nolting S, Braütigam M, Weidinger G. Terbinafine in onychomycosis with involvement by non dermatophyte fungi. Br J Dermatol 1994; 130 (suppl 43) 16 – 21
23. Segal R, Guadelli L, Kritzman A, David M. Treatment of Candida nail infection with terbinafine. Presented at 2nd Annual International Summit on Cutaneous Antifungal Therapy, Boston, MA, Nov, 10-13, 1994
24. Marchetti A, et al. Pharmacoeconomic analysis of oral therapies for onychomycosis; a US model. Clin Ther 1996; 18: 757 – 77
25. O'Sullivan D, et al. Post marketing surveillance of oral terbinafine in the UK - report of a large cohort study. Br J Clin Pharmacol 1996; 42: 559 – 65
26. Inman W, Kuboter K, Pearce G, Wilton L. PEM Report and itraconazole. Pharmacoepidemiol Drug Safety 1993; 2: 423 – 43